全文获取类型
收费全文 | 1689529篇 |
免费 | 148330篇 |
国内免费 | 31731篇 |
专业分类
耳鼻咽喉 | 19450篇 |
儿科学 | 47656篇 |
妇产科学 | 40583篇 |
基础医学 | 222298篇 |
口腔科学 | 42194篇 |
临床医学 | 171039篇 |
内科学 | 323044篇 |
皮肤病学 | 35823篇 |
神经病学 | 127377篇 |
特种医学 | 68849篇 |
外国民族医学 | 498篇 |
外科学 | 241051篇 |
综合类 | 100660篇 |
现状与发展 | 88篇 |
一般理论 | 442篇 |
预防医学 | 132104篇 |
眼科学 | 38375篇 |
药学 | 132950篇 |
426篇 | |
中国医学 | 26402篇 |
肿瘤学 | 98281篇 |
出版年
2021年 | 26306篇 |
2020年 | 19326篇 |
2019年 | 20448篇 |
2018年 | 25199篇 |
2017年 | 22058篇 |
2016年 | 23230篇 |
2015年 | 30736篇 |
2014年 | 40458篇 |
2013年 | 48339篇 |
2012年 | 63909篇 |
2011年 | 70063篇 |
2010年 | 45461篇 |
2009年 | 41042篇 |
2008年 | 57168篇 |
2007年 | 59343篇 |
2006年 | 59512篇 |
2005年 | 57230篇 |
2004年 | 48989篇 |
2003年 | 47668篇 |
2002年 | 43510篇 |
2001年 | 73893篇 |
2000年 | 75618篇 |
1999年 | 64433篇 |
1998年 | 21821篇 |
1997年 | 19974篇 |
1996年 | 19867篇 |
1995年 | 19846篇 |
1994年 | 18148篇 |
1993年 | 16032篇 |
1992年 | 49238篇 |
1991年 | 47660篇 |
1990年 | 45560篇 |
1989年 | 43172篇 |
1988年 | 39890篇 |
1987年 | 39052篇 |
1986年 | 36658篇 |
1985年 | 35212篇 |
1984年 | 26656篇 |
1983年 | 22303篇 |
1982年 | 13930篇 |
1981年 | 12552篇 |
1979年 | 23626篇 |
1978年 | 17080篇 |
1977年 | 14381篇 |
1976年 | 13165篇 |
1975年 | 13716篇 |
1974年 | 16101篇 |
1973年 | 15407篇 |
1972年 | 14202篇 |
1971年 | 13041篇 |
排序方式: 共有10000条查询结果,搜索用时 296 毫秒
81.
目的探讨接受选择性淋巴结照射(ENI)的食管鳞癌患者预后和失败模式。方法回顾性分析2005年1月至2012年12月河北医科大学第四医院收治的179例符合入组条件的食管鳞癌患者,分析肿瘤局部相关因素预测患者预后的价值,分析影响患者近期疗效、预后的影响因素,并对影响患者总生存率(OS)、无进展生存率(PFS)和复发的指标分别进行单因素和多因素分析。结果全组患者1、3、5年OS和PFS分别为77.1%、40.1%、26.0%和62.6%、30.6%、20.3%。多因素分析结果显示声音嘶哑、cN分期、cTNM分期、GTV-横径(GTV-D)和GTV-体积/长度(GTV-V/L)为影响患者OS的独立性影响因素(P<0.05);声音嘶哑、cTNM分期和近期疗效为影响患者PFS的独立性影响因素(P<0.05)。全组有75例(41.9%)患者出现复发,61例(34.1%)远处转移,其中19例(10.6%)为合并复发和远处转移。75例复发患者中64例(85.3%)患者为单纯食管复发,4例(5.3%)为单纯淋巴结复发,另7例(9.3%)患者为食管合并淋巴结复发。治疗后达完全缓解(CR)的63例患者中有18例患者出现复发,其中仅有2例患者出现淋巴结复发;logistic多因素分析结果显示患者周边组织/器官受侵、GTV-D和近期疗效为影响患者复发的独立性影响因素(P<0.05)。结论食管鳞癌患者接受ENI确实可行,其失败主要模式仍为食管复发;治疗前声音嘶哑、GTV-D和GTV-V/L较大、临床分期较晚和近期疗效不佳为患者预后较差的指标;肿瘤周边组织受侵、GTV-D和近期疗效是影响患者失败的独立性因素。 相似文献
82.
Whitney S. Brandt Wanpu Yan Jian Zhou Kay See Tan Joseph Montecalvo Bernard J. Park Prasad S. Adusumilli James Huang Matthew J. Bott Valerie W. Rusch Daniela Molena William D. Travis Mark G. Kris Jamie E. Chaft David R. Jones 《The Journal of thoracic and cardiovascular surgery》2019,157(2):743-753.e3
Objective
Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.Methods
Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.Results
In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.Conclusions
Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection. 相似文献83.
Metabolism describes the series of chemical reactions that are concerned with the provision of energy to biological systems. They may be divided into reactions involved in energy yield (catabolism: demand exceeds supply), and energy storage (anabolism: supply exceeds demand). Regulation of these pathways is critical for homeostasis, and derangements in metabolism are seen in a wide variety of pathological processes. Understanding metabolism is key to the treatment of many diseases, notably diabetes, as well as underpinning clinical nutritional support. 相似文献
84.
85.
Die Anaesthesiologie - 相似文献
86.
87.
88.
We report a Chinese family with members affected by epidermolytic ichthyosis (EI), caused by KRT gene mutations. The proband was a 14‐year‐old boy who had simultaneous appearance of nephroblastoma and epidermolytic ichthyosis (EI). Both the patient and his mother exhibited the specific clinical and pathological manifestations of EI. We analysed all exons and flanking sequences of the KRT1 and KRT10 genes using PCR, and found that the proband and his mother had a G>C transition at nucleotide position 1432 in exon 7 of KRT1, resulting in an amino acid substitution of glutamate (GAA) to glutamine (CAA) at codon 478 (E478Q). The KRT10 gene had no mutations. 相似文献
89.
90.
Alina Goldenberg B.A. Catalina Matiz M.D. Lawrence F. Eichenfield M.D. 《Pediatric dermatology》2015,32(4):e191-e192
Henna, derived from a combination of natural leaves and coloring additives, is a common decorative dye traditionally used in many Islamic religious celebrations. Para‐phenylenediamine (PPD), a major component of black henna tattoo, is a strong sensitizer and common allergen. We report a case of severe connubial allergic contact dermatitis after black henna heterotransfer in a girl. 相似文献